Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 07, 2024 02:08 ET | Source: Avillion

Avillion announces positive high-level results from Phase III BATURA trial with AstraZeneca’s inhaled anti-inflammatory medication Airsupra in asthma patients

Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysisPhase IIIb clinical development of Airsupra was conducted by Avillion under an...